Browsing by Author "Berman, Phillip W"
Now showing items 1-3 of 3
-
Comparative immunogenicity of HIV-1 clade C envelope proteins for prime/boost studies.
Smith, Douglas H; Winters-Digiacinto, Peggy; Mitiku, Misrach; O'Rourke, Sara; Sinangil, Faruk; Wrin, Terri; Montefiori, David C; ... (8 authors) (PLoS One, 2010-08-11)BACKGROUND: Previous clinical efficacy trials failed to support the continued development of recombinant gp120 (rgp120) as a candidate HIV vaccine. However, the recent RV144 HIV vaccine trial in Thailand showed that a prime/boost ... -
HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees.
Yates, Nicole L; deCamp, Allan C; Korber, Bette T; Liao, Hua-Xin; Irene, Carmela; Pinter, Abraham; Peacock, James; ... (22 authors) (Journal of virology, 2018-04)Induction of broadly cross-reactive antiviral humoral responses with the capacity to target globally diverse circulating strains is a key goal for HIV-1 immunogen design. A major gap in the field is the identification of ... -
Magnitude and breadth of a nonprotective neutralizing antibody response in an efficacy trial of a candidate HIV-1 gp120 vaccine.
Gilbert, Peter; Wang, Maggie; Wrin, Terri; Petropoulos, Chris; Gurwith, Marc; Sinangil, Faruk; D'Souza, Patricia; ... (13 authors) (J Infect Dis, 2010-08-15)BACKGROUND: A candidate vaccine consisting of human immunodeficiency virus type 1 (HIV-1) subunit gp120 protein was found previously to be nonprotective in an efficacy trial (Vax004) despite strong antibody responses against ...